Barclays’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-6
Closed -$22K 4040
2021
Q3
$22K Sell
6
-2,449,972
-100% -$8.98B ﹤0.01% 3609
2021
Q2
$450M Sell
2,449,978
-1,128,398
-32% -$207M 0.21% 47
2021
Q1
$547M Buy
3,578,376
+3,212,242
+877% +$491M 0.29% 29
2020
Q4
$57.2M Sell
366,134
-42,407
-10% -$6.63M 0.03% 283
2020
Q3
$46.8M Buy
408,541
+172,430
+73% +$19.7M 0.03% 280
2020
Q2
$26.5M Sell
236,111
-149,218
-39% -$16.7M 0.02% 372
2020
Q1
$34.6M Sell
385,329
-99,558
-21% -$8.94M 0.03% 268
2019
Q4
$52.4M Sell
484,887
-103,943
-18% -$11.2M 0.03% 334
2019
Q3
$57.7M Buy
588,830
+209,233
+55% +$20.5M 0.04% 279
2019
Q2
$49.7M Buy
379,597
+112,799
+42% +$14.8M 0.03% 341
2019
Q1
$36.1M Sell
266,798
-124,020
-32% -$16.8M 0.02% 351
2018
Q4
$38M Sell
390,818
-80,780
-17% -$7.86M 0.03% 313
2018
Q3
$65.6M Buy
471,598
+177,468
+60% +$24.7M 0.05% 217
2018
Q2
$36.5M Sell
294,130
-312,897
-52% -$38.8M 0.03% 312
2018
Q1
$67.7M Buy
607,027
+32,039
+6% +$3.57M 0.05% 232
2017
Q4
$68.8M Sell
574,988
-59,099
-9% -$7.07M 0.06% 195
2017
Q3
$89M Sell
634,087
-214,964
-25% -$30.2M 0.09% 113
2017
Q2
$103M Buy
849,051
+589,735
+227% +$71.8M 0.11% 90
2017
Q1
$31.4M Buy
259,316
+95,536
+58% +$11.6M 0.03% 233
2016
Q4
$20M Buy
163,780
+51,137
+45% +$6.26M 0.02% 318
2016
Q3
$13.8M Sell
112,643
-58,004
-34% -$7.11M 0.02% 361
2016
Q2
$19.9M Buy
170,647
+68,955
+68% +$8.05M 0.03% 295
2016
Q1
$14.1M Sell
101,692
-129,527
-56% -$18M 0.02% 359
2015
Q4
$43.9M Buy
231,219
+72,209
+45% +$13.7M 0.05% 168
2015
Q3
$24.8M Sell
159,010
-417,052
-72% -$65.1M 0.03% 247
2015
Q2
$104M Buy
576,062
+359,783
+166% +$64.8M 0.12% 78
2015
Q1
$37.4M Sell
216,279
-3,289
-1% -$569K 0.04% 246
2014
Q4
$40.6M Buy
219,568
+8,165
+4% +$1.51M 0.04% 225
2014
Q3
$34.9M Buy
211,403
+18,275
+9% +$3.02M 0.03% 261
2014
Q2
$30.1M Sell
193,128
-9,737
-5% -$1.52M 0.03% 280
2014
Q1
$30.8M Sell
202,865
-79,346
-28% -$12.1M 0.03% 281
2013
Q4
$37.3M Buy
282,211
+17,600
+7% +$2.32M 0.04% 263
2013
Q3
$30.7M Buy
264,611
+98,559
+59% +$11.4M 0.04% 254
2013
Q2
$15.3M Buy
+166,052
New +$15.3M 0.02% 411